Cellvizio® is the real-time in vivo cellular imaging platform that revolutionizes the way physicians diagnose and treat patients.

Joined March 2011
963 Photos and videos
Happy National Cancer @SurvivorsDay! To every survivor,  your strength inspires the entire healthcare community. We're proud to support the physicians and teams that make more survival stories possible. #NCSD2026 #EarlyDetection #SeeCellsChangeLives
1
31
An enriching #pancreaticcyst nCLE with #Cellvizio Workshop at @Hopital_Mermoz! Experts from France, Spain, & Serbia united to share the latest evidence & techniques to effectively risk-stratify pancreatic cysts, making a profound difference for patients. #GITwitter
2
55
A new @UEGJournal study shows the impact of triple healing for #IBD: histological remission & an intact intestinal barrier in both the ileum and colon. Triple healing: 0 relapses in 29 patients over 24 months. Fall short of it: ~33% relapse. hubs.la/Q04k57df0 #GITwitter
1
2
94
The @WorldGastroOrg established #WDHD2026 to raise awareness about digestive health issues & promote preventative measures. As a global medical device company, we’re dedicated to providing solutions to take charge of gut health. hubs.la/Q04ghQC80 #GITwitter
2
44
#ICYMI @CellTolerance is officially expanding into the United Arab Emirates & Turkey! With #IBS & food intolerances impacting up to 27% of the population in these markets, our precision diagnostics are ready to make a major impact. hubs.ly/Q04hyRD10 #Cellvizio $ALMKT
1
187
@MaunaKeaTech has secured regulatory clearances for #Cellvizio in the UAE & Turkey and the first @CellTolerance commercial installation in a region where #IBS & #FoodIntolerances affect up to 27% of the population. Read the full PR: hubs.la/Q04hn2GD0 $ALMKT #GITwitter
1
2
74
#WorldIBDDay raises awareness for Crohn’s Disease & Ulcerative Colitis, two chronic inflammatory bowel diseases (#IBD) affecting millions worldwide. To learn how #Cellvizio can be superior to conventional severity scoring, visit: hubs.la/Q04ghTyc0 @CrohnsColitisFn
3
76
The stakes for early detection have never been higher. The road to Complete Remission of Intestinal Metaplasia (CRIM) is long. We can't control the rise of the disease alone, but with #Cellvizio, we can control how we find and treat it. hubs.la/Q04fVHYm0 #GITwitter
2
3
192
#Cellvizio offers unprecedented cellular-level visualization, empowering physicians to treat patients with unmatched precision. This groundbreaking technology is redefining #healthcare. Discover the transformative impact: #SeeCellsChangeLives #GITwitter
1
2
124
Pancreatic cysts: over-resected AND under-detected. #DDW2026 data shows #Cellvizio outperforms conventional cyst fluid analysis (CEA, amylase, cytology, glucose) helping the right patients get surgery & the right patients avoid it. hubs.la/Q04fJY9w0 @som_krishna #GITwitter

4
126
New #DDW2026 data marks a pivotal moment for patients struggling w/ unexplained gut issues. @CellTolerance CLE (#Cellvizio) gives physicians real-time, cellular-level visualization of the intestinal mucosa that conventional tests often miss. hubs.la/Q04ftQnV0 #GITwitter

1
3
5
293
Proud to be part of the 4th Annual Pancreatic Cyst Consortium at @DDWMeeting, organized by @som_krishna, with record attendance & expert discussions on advancing #pancreaticcyst diagnostic & management strategies to improve patient outcomes. Thank you to all involved! #GITwitter
3
6
129
Major clinical momentum for #Cellvizio at #DDW2026! 10 new abstracts spanning #pancreaticcysts, IBD assessment, gastric disease, and #foodintolerance, Read more: hubs.la/Q04dShqv0 @DDWMeeting @CellTolerance #GITwitter
1
2
127
Advancement in early #esophagealcancer detection could significantly impact global health outcomes! This study demonstrates how #Cellvizio is empowering #AI deep learning models to detect with incredible accuracy. Learn more: hubs.la/Q04dz6Jx0 #EarlyDetection #GITwitter
1
1
98
Cellvizio® by Mauna Kea Technologies retweeted
🎙️ 3 Questions à Sacha Loiseau (Mauna Kea Technologies) @sachaloiseau, Président Directeur Général de @maunakeatech, revient sur le renouveau de la société, les raisons de l'excellente dynamique commerciale aux U.S. et les bonnes performances de Cell Tolerance.
3
4
227
@maunakeatech reports a transformative 2025 marked by record sales and a strengthened balance sheet. This momentum has already extended into a record-breaking start to 2026! hubs.la/Q04d5khD0 $ALMKT #SeeCellsChangeLives
1
3
138
April is #EsophagealCancerAwarenessMonth. GERD → Barrett's → Esophageal Cancer is a progression that #Cellvizio can help physicians interrupt this path. Real-time cellular visualization during endoscopy changes the equation. hubs.la/Q04cN_zm0 #GITwitter
1
2
102
Today is #WorldIBSDay2026. #IBS and the symptoms are real. New multi-disciplinary approaches like multi-disciplinary approaches like @celltolerance powered by #Cellvizio, are helping physicians finally see what's happening at the gut level. hubs.ly/Q04crP2D0 #GITwitter
2
101
Cellvizio® by Mauna Kea Technologies retweeted
First @CellTolerance cases at @Clinica_Teknon! Powered by #Cellvizio, #CellTolerance helps clinicians identify food triggers for precise, individualized #IBS care. Thrilled that patients in Spain now have access to this revolutionary test! #GITwitter #guthealth
1
2
76
Our reported Q1 2026 results reflect the growing global adoption of #Cellvizio and the impact of our @CellTolerance investment. This highlights Cellvizio’s growing role as a standard of care in #pancreaticcyst evaluation & patient mngmt. hubs.la/Q04cbHBg0 $ALMKT
1
2
108